We are live on ! Find out more
NMTR

9 Meters Biopharma

Delisted

NMTR was delisted on the 25th of July, 2023.

1 hedge funds and large institutions have $0 invested in 9 Meters Biopharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

100% less capital invested

Capital invested by funds: $6.43K → $0 (-$6.43K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

NMTR Hedge Fund Activity: Q3 2024 in Review

1 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2024, worth a combined $0 — down 100% from $6.43K a quarter earlier.

Fund positioning in NMTR was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

  • 1 institutional investor held 9 Meters Biopharma (NMTR) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $0 of 9 Meters Biopharma stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new 9 Meters Biopharma positions in Q3 2024 and 0 closed out.

Based on aggregated 13F filings for Q3 2024.